D. Liénard

Discipline

Psychologie (1) Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (9) Recensions (1)

Co-auteur

Date

Source

Mot-clé

Human beings (9) Antigens (7) Patients (6) Melanoma (6) Patients (6) T cells (5) Cells (5) Blood (4) Older people (4) membrane (3) exposition (3) cytotoxicité (3) adulte (3) Phenotype (3) Peptides (3) Lymphocyte transformation (3) Immunologic memory (3) Receptors (3) adulte (3) administration (2) temps (durée) (2) étable (2) pharmacocinétique (2) analyse (2) dose (2) dosage (2) cancer (2) Treatment (2) Chemotherapy (2) Cancer (2)

Documents écrit par D. Liénard (9) | parle de D. Liénard (0)

A phase I pharmacokinetic study of hypoxic abdominal stop-flow perfusion with gemcitabine in patients with advanced pancreatic cancer and refractory malignant ascites
A. Kuemmerle et al. (2009)
IL-12 controls cytotoxicity of a novel subset of self-antigen-specific human CD28+ cytolytic T cells.
C. Barbey et al. (2007)
Ex vivo detectable human CD8 T-cell responses to cancer-testis antigens.
P. Baumgaertner et al. (2006)
Thymic selection generates a large T cell pool recognizing a self-peptide in humans.
A. Zippelius et al. (2002)
High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals
M. J. Pittet et al.
Sequential administration of temozolomide and fotemustine: depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours
M. Gander et al.
In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.
D.E. Speiser et al. (1999)
Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
D. Valmori et al. (1999)
Recognition of tumor-associated antigens by T-lymphocytes: perspectives for peptide-based vaccines.
J.C. Cerottini et al. (1996)